feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Gold prices rise today

trending

Wockhardt pharmaceutical company operations

trending

Poll official BLO dies by suicide

trending

Ukraine intercepts Russian jet drones

trending

WBSSC removes tainted candidates

trending

UPPSC PCS Prelims Result declared

trending

Gavaskar slams Shukri Conrad remark

trending

Osimhen joins Galatasaray due family

trending

Istanbul flights save hundreds

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Nose Drops Fight Deadly Brain Cancer

Nose Drops Fight Deadly Brain Cancer

24 Nov

•

Summary

  • Nasal drops deliver tumor-fighting medicine to the brain.
  • Method effectively treats glioblastoma by boosting immune response.
  • Technology uses engineered nanostructures called spherical nucleic acids.
Nose Drops Fight Deadly Brain Cancer

A novel approach using nasal drops shows promise for treating aggressive brain cancers, offering a non-invasive alternative to current therapies. Researchers have developed a technology that delivers tumor-fighting medicine directly to the brain through the nose, effectively boosting the immune system's response against glioblastoma in mice.

This new method employs spherical nucleic acids (SNAs), engineered nanostructures that activate the stimulator of interferon genes (STING) pathway. This activation is crucial for 'warming up' cold tumors, which are typically resistant to immunotherapy, thereby enhancing the efficacy of treatments like checkpoint inhibitors.

The development marks a significant step toward more effective and less invasive treatments for glioblastoma. Further studies are ongoing to determine how these findings translate to human patients, offering hope for safer and more potent therapies for brain cancer and other immune-resistant malignancies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Researchers are using specially engineered nasal drops to deliver tumor-fighting medicine directly to the brain, boosting the immune response against glioblastoma.
SNAs are nanostructures that activate the STING pathway, reprogramming the brain's immune microenvironment to better fight glioblastoma tumors.
The nasal spray technology is currently in development and has shown effectiveness in mice studies; it is not yet consumer-ready for clinical use.

Read more news on

Healthside-arrow

You may also like

Brain's Immune Cells: New Alzheimer's Protectors?

13 hours ago • 4 reads

Boxers' Brains Reveal Hidden Damage Pathway

13 hours ago • 5 reads

Boost Activity, Cut Dementia Risk by 45%

28 Nov • 23 reads

article image

Young Adults Face Cancer Spread Risk

28 Nov • 22 reads

article image

Dual Cancer Fight: Lung Tumor Found Alongside Breast Cancer

28 Nov • 21 reads

article image